Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gallistl

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 11, 2000
Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitroM Koestenberger, S Gallistl, G Cvirn, et al.
European Journal of Pediatrics|April 1, 1995
Inherited resistance to activated protein C in a boy with multiple thromboses in early infancyW Zenz, W Muntean, S Gallistl, et al.
Diabetes Care|September 8, 2000
Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescentsS Gallistl, K Sudi, H Mangge, et al.
Metabolism: Clinical and Experimental|October 5, 2001
Determinants of homocysteine during weight reduction in obese children and adolescentsS Gallistl, K M Sudi, W Erwa, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|April 25, 2001
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescentsS Gallistl, K M Sudi, G Cvirn, et al.
Pediatrics|July 1, 1995
Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemiaW Zenz, W Muntean, S Gallistl, et al.
Thrombosis and Haemostasis|August 1, 1995
Treatment of fulminant meningococcemia with recombinant tissue plasminogen activatorW Zenz, W Muntean, G Zobel, et al.
Metabolism: Clinical and Experimental|July 26, 2000
Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescentsK M Sudi, S Gallistl, G Weinhandl, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 12, 2001
Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescentsS Gallistl, K M Sudi, B Leschnik, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 10, 2000
The relationship between different subcutaneous adipose tissue layers, fat mass and leptin in obese children and adolescentsK M Sudi, S Gallistl, E Tafeit, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 11, 2000
Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitroM Koestenberger, S Gallistl, G Cvirn, et al.
European Journal of Pediatrics|April 1, 1995
Inherited resistance to activated protein C in a boy with multiple thromboses in early infancyW Zenz, W Muntean, S Gallistl, et al.
Diabetes Care|September 8, 2000
Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescentsS Gallistl, K Sudi, H Mangge, et al.
Metabolism: Clinical and Experimental|October 5, 2001
Determinants of homocysteine during weight reduction in obese children and adolescentsS Gallistl, K M Sudi, W Erwa, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|April 25, 2001
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescentsS Gallistl, K M Sudi, G Cvirn, et al.
Pediatrics|July 1, 1995
Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemiaW Zenz, W Muntean, S Gallistl, et al.
Thrombosis and Haemostasis|August 1, 1995
Treatment of fulminant meningococcemia with recombinant tissue plasminogen activatorW Zenz, W Muntean, G Zobel, et al.
Metabolism: Clinical and Experimental|July 26, 2000
Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescentsK M Sudi, S Gallistl, G Weinhandl, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 12, 2001
Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescentsS Gallistl, K M Sudi, B Leschnik, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 10, 2000
The relationship between different subcutaneous adipose tissue layers, fat mass and leptin in obese children and adolescentsK M Sudi, S Gallistl, E Tafeit, et al.
Pageof 5